AU663000B2 - Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions - Google Patents

Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions Download PDF

Info

Publication number
AU663000B2
AU663000B2 AU46262/93A AU4626293A AU663000B2 AU 663000 B2 AU663000 B2 AU 663000B2 AU 46262/93 A AU46262/93 A AU 46262/93A AU 4626293 A AU4626293 A AU 4626293A AU 663000 B2 AU663000 B2 AU 663000B2
Authority
AU
Australia
Prior art keywords
adsorbate
active compound
preparation
pyridine
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU46262/93A
Other languages
English (en)
Other versions
AU4626293A (en
Inventor
Theophil Hornykiewytsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU4626293A publication Critical patent/AU4626293A/en
Application granted granted Critical
Publication of AU663000B2 publication Critical patent/AU663000B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU46262/93A 1992-09-11 1993-09-10 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions Ceased AU663000B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4230371 1992-09-11
DE4230371 1992-09-11

Publications (2)

Publication Number Publication Date
AU4626293A AU4626293A (en) 1994-03-17
AU663000B2 true AU663000B2 (en) 1995-09-21

Family

ID=6467712

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46262/93A Ceased AU663000B2 (en) 1992-09-11 1993-09-10 Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions

Country Status (13)

Country Link
EP (1) EP0587137A1 (index.php)
JP (1) JPH06192093A (index.php)
KR (1) KR940006583A (index.php)
AU (1) AU663000B2 (index.php)
CA (1) CA2105913A1 (index.php)
FI (1) FI933954L (index.php)
HU (1) HUT67577A (index.php)
IL (1) IL106953A0 (index.php)
MX (1) MX9305578A (index.php)
NO (1) NO933237L (index.php)
NZ (1) NZ248627A (index.php)
TW (1) TW222585B (index.php)
ZA (1) ZA936695B (index.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ267002A (en) * 1993-06-04 1997-07-27 Warner Lambert Co Chewable cold/sinus relief preparation comprising antihistamine and decongestant in a carrier consisting of silicon dioxide
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
BR9916361A (pt) * 1998-12-18 2002-11-05 Abbott Lab Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia
EP1765297A2 (en) * 2004-06-28 2007-03-28 LifeCycle Pharma A/S Porous tablets as carriers for liquid formulations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
EP0158120A1 (de) * 1984-03-13 1985-10-16 BASF Aktiengesellschaft Verfahren zur Herstellung von fliessfähigen Cholinchlorid-Kieselsäure-Pulvern
EP0487335A1 (en) * 1990-11-20 1992-05-27 Montague Cecil Solomon Pharmaceutical dosage forms of dihydropyridines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
EP0158120A1 (de) * 1984-03-13 1985-10-16 BASF Aktiengesellschaft Verfahren zur Herstellung von fliessfähigen Cholinchlorid-Kieselsäure-Pulvern
EP0487335A1 (en) * 1990-11-20 1992-05-27 Montague Cecil Solomon Pharmaceutical dosage forms of dihydropyridines

Also Published As

Publication number Publication date
EP0587137A1 (de) 1994-03-16
NO933237D0 (no) 1993-09-10
HU9302555D0 (en) 1993-11-29
FI933954A7 (fi) 1994-03-12
TW222585B (index.php) 1994-04-21
MX9305578A (es) 1994-03-31
NO933237L (no) 1994-03-14
IL106953A0 (en) 1993-12-28
KR940006583A (ko) 1994-04-25
FI933954L (fi) 1994-03-12
AU4626293A (en) 1994-03-17
JPH06192093A (ja) 1994-07-12
HUT67577A (en) 1995-04-28
FI933954A0 (fi) 1993-09-09
ZA936695B (en) 1994-04-05
NZ248627A (en) 1995-01-27
CA2105913A1 (en) 1994-03-12

Similar Documents

Publication Publication Date Title
JP4334616B2 (ja) 湿式粒状化による投与単位体を製造する方法
JPS62135418A (ja) 薬用組成物
JPS5810513A (ja) 新規なベンドロフルメチアジド配合物およびその調整方法
EP0159852A2 (en) Directly compressible pharmaceutical compositions
JP2000191516A (ja) 経口固形組成物
JP4070402B2 (ja) 低置換度ヒドロキシプロピルセルロース及びその製造方法
KR20010020163A (ko) 안정화된 티볼론 조성물
HK59894A (en) Pharmaceutical compositions containing clodronate, and process for their preparation
JPS62242616A (ja) ロキソプロフエン・ナトリウム含有製剤
AU663000B2 (en) Adsorbate of an auxiliary mixture and a non-solid active compound for the preparation of pharmaceutical compositions
JPS58109412A (ja) ニフエジピン固形製剤
JP2689458B2 (ja) 粒状ないし粉末状のビタミンｂ▲下１▼▲下２▼類含有組成物
JPS6320409B2 (index.php)
JPH0478615B2 (index.php)
JP4774739B2 (ja) 漢方エキス含有錠剤組成物およびその製造方法
JP2669517B2 (ja) ロキソプロフェン・ナトリウム含有固形製剤
US4536511A (en) Medicaments containing muzolimine, their use and processes for their production
JPH04159222A (ja) 経口投与用固形薬剤の製造方法
EP1976522A1 (en) Pharmaceutical composition containing montelukast
JP2986256B2 (ja) 血液透析用顆粒剤
JPH06157313A (ja) ニカルジピン持続性製剤とその製造方法
JP2004010575A (ja) 溶解性を改善した医薬組成物
JPH037645B2 (index.php)
JP4591742B2 (ja) ジオクチルソジウムスルホサクシネート配合製剤およびその製造方法
TW202227047A (zh) 甲狀腺荷爾蒙的製劑化方法